Immunotherapy prevents long-term disability in relapsing multiple sclerosis over 15 years
Tomáš Kalinčík, Sifat Sharmin, Charles Benjamin Malpas, Tim D. Spelman, Dana Horáková, Eva Havrdová, María Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Vilija Jokubaitis, Anneke van der Walt, , on behalf of the MSBase Study group
This study shows that immunotherapy reduces disability and relapses in relapsing multiple sclerosis over 15 years.
bioRxiv · Aug 23, 2019 · PreprintNeuroscience